The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma Simona Miceska et al, 2023, Radiology and Oncology CrossRef
Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis Ramy R. Saleh et al, 2022, Molecular Diagnosis & Therapy CrossRef
Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer? Yun Ye et al, 2018, Medicine CrossRef
Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer Estrid Høgdall et al, 2020, International Journal of Gynecologic Cancer CrossRef
Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma Li-Jun Huang et al, 2018, Medicine CrossRef
Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis Chen Zhang et al, 2021, Frontiers in Oncology CrossRef
The role of B7-H4 in ovarian cancer immunotherapy: current status, challenges, and perspectives Lu Zhou et al, 2024, Frontiers in Immunology CrossRef
Prediction of the treatment response in ovarian cancer: a ctDNA approach Mina Sharbatoghli et al, 2020, Journal of Ovarian Research CrossRef
New checkpoints in cancer immunotherapy Ling Ni et al, 2017, Immunological Reviews CrossRef
Expression of STAT1 is positively correlated with PD-L1 in human ovarian cancer Fangran Liu et al, 2020, Cancer Biology & Therapy CrossRef
Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients
Anna Pawłowska et al, 2020, Cancer Management and Research CrossRef
Expression and correlation of PD-L1 and HER2 in oesophageal squamous cell carcinoma Lulu Rong et al, 2024, Journal of Clinical Pathology CrossRef